XML 50 R39.htm IDEA: XBRL DOCUMENT v3.25.1

Commitments and Contingencies (Details) - USD ($) $ in Thousands		3 Months Ended	12 Months Ended
	Sep. 30, 2023	Mar. 31, 2025	Dec. 31, 2023	Dec. 30, 2022
Mayne Pharma Agreement [Member]
Commitments and Contingencies [Line Items]
Acquisition of net working capital				$ 12,100
Adjustment of increase in accrual on working capital	$ 2,000
Working capital amounts			$ 5,500
Maximum [Member]
Commitments and Contingencies [Line Items]
Increased allowance for net working capital			5,500
Minimum [Member]
Commitments and Contingencies [Line Items]
Increased allowance for net working capital			$ 2,000
Paragraph IV Certification Notice Letter [Member]
Commitments and Contingencies [Line Items]
Legal costs		$ 2,334

X

- Definition

Amount of adjustment of the increase in accruals on working capital.

+ References

No definition available.

+ Details

Name:	txmd_AdjustmentOfIncreaseInAccrualOnWorkingCapital
Namespace Prefix:	txmd_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

X

- Definition

Cash received for net working capital.

+ References

No definition available.

+ Details

Name:	txmd_CashReceivedForNetWorkingCapital
Namespace Prefix:	txmd_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

X

- Definition

Amount of increased allowance for net working capital.

+ References

No definition available.

+ Details

Name:	txmd_IncreasedAllowanceForNetWorkingCapital
Namespace Prefix:	txmd_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

X

- Definition

Working capital amounts.

+ References

No definition available.

+ Details

Name:	txmd_WorkingCapitalAmounts
Namespace Prefix:	txmd_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

X

- Definition

The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section 45
-Paragraph 3
-Subparagraph (k)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479105/946-220-45-3

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 946
-SubTopic 220
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.6-07(2)(b))
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1

Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef
-Name Accounting Standards Codification
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(6))
-SubTopic 10
-Topic 220
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2

+ Details

Name:	us-gaap_LegalFees
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

X

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_OtherCommitmentsLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Details

Name:	us-gaap_TypeOfArrangementAxis=txmd_MaynePharmaAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_RangeAxis=srt_MaximumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	srt_RangeAxis=srt_MinimumMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	txmd_LegalProceedingAxis=txmd_ParagraphFourCertificationNoticeLetterMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: